How it may work
Inhibits mTOR signalling and has robust lifespan effects in several animal models.
Guide-level evidence orientationEvidence level D
Level D describes sparse or indirect human evidence for this exact question; read the conclusion for direction and limits.
This guide-level grade is an orientation, not a direction-of-effect label, product grade, claim or personal recommendation.Why people are interested
A medicine that turns down the mTOR growth pathway. Animal longevity results are striking, but human ageing evidence and safety trade-offs remain unresolved.
Library trackMedical research
Last reviewed20 Aug 2026
Guide scopeIngredient research only
What people have studied
Human studies in ageing-related contexts are limited and do not establish routine longevity use.
What to consider
Immunosuppression, infection, lipid, blood and wound-healing risks require specialist oversight.
Local pathway
Prescription medical research only. Not sold by CELLIVITY.
Sources + indexes
See where the explanation comes from.
Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.